How long does dietary supplement contract manufacturing take?

Custom supplement formulation and manufacturing typically takes 4–8 months from signed agreement to first delivered shipment. Stock/private label products can move faster — typically 6–12 weeks. The timeline includes formulation development (4–8 weeks for custom), regulatory review, ingredient sourcing, manufacturing, QC testing, and packaging. Brands should plan for the longer end of these ranges for first production runs.

How do I find and vet a U.S. dietary supplement contract manufacturer?

Start by filtering on the dosage form you need — not all CMOs produce all formats. Then verify: FDA registration (searchable at FDA.gov), cGMP certification by a third party (NSF, Informed Choice, UL, NPA), analytical testing capabilities (in-house lab vs. outsourced), MOQ compatibility with your launch volume, formulation support availability, and experience in your specific supplement category. Request references and samples before committing to a production run.

What is 21 CFR Part 111 and why does it matter for supplement brands?

21 CFR Part 111 is the FDA's Current Good Manufacturing Practices regulation for dietary supplements. It requires that manufacturers establish and follow written procedures for production, quality control, testing, sanitation, equipment, and record-keeping. Brands that partner with CMOs operating under 21 CFR Part 111 have documented evidence of quality control — which protects against recalls, retailer audits, and FDA enforcement actions.

Dietary Supplement Contract Manufacturer USA: 2026 Brand Owner's Guide

Q: What is the minimum order quantity for dietary supplement contract manufacturing?

MOQs vary significantly by dosage form. Capsules and tablets typically start at 5,000–25,000 units for stock formulas and 10,000–50,000 for custom formulations. Oral dissolving films (ODFs) can start as low as 3,000 units at specialty manufacturers. Gummies typically require 10,000–50,000 units. Powders and stick packs often start at 1,000–5,000 units. Always confirm MOQ by dosage form with specific CMOs during initial outreach.

Q: Do I need FDA approval to sell dietary supplements in the USA?

No — dietary supplements are not FDA approved. The FDA does not approve dietary supplement formulas or products before they go to market. Instead, the supplement manufacturer must be FDA registered and operate under 21 CFR Part 111 cGMP regulations. You are responsible for ensuring your product is safe and that any structure/function claims are truthful and substantiated. The FDA takes enforcement action after the fact if products are unsafe or mislabeled.

The U.S. dietary supplement industry generates $69 billion annually, with more than 80% of American adults using at least one supplement product. Behind every bottle, packet, or strip on the shelf is a manufacturer — and for the vast majority of supplement brands, that manufacturer is a contract manufacturing organization (CMO) rather than an in-house facility.

Choosing the right dietary supplement contract manufacturer is the most consequential decision a supplement brand will make. The wrong CMO means quality failures, missed timelines, compliance gaps, and products that never scale. The right CMO is a long-term growth partner. This guide covers everything supplement brands need to know in 2026 — from CMO types and regulatory requirements to dosage forms, timelines, and how tariff changes are reshaping the sourcing landscape.

FDA-registered USA dietary supplement contract manufacturing facility — cGMP certified production — U.S.-based dietary supplement CMOs must operate under 21 CFR Part 111 cGMP regulations

The U.S. Dietary Supplement Market in 2026

The U.S. supplement market reached $69 billion in 2024 and continues to grow at 3–5% annually, driven by aging demographics, preventive health trends, and growing consumer interest in performance and longevity. An estimated 50,000+ unique supplement SKUs are commercially available in the United States, spanning categories from basic vitamins and minerals to specialized nootropics, hormone-supporting botanicals, and advanced delivery formats.

The fastest-growing supplement categories in 2026 include sleep support (driven by melatonin and adaptogen demand), cognitive function, gut health and prebiotics, longevity and cellular health (NAD+, NMN, spermidine), and GLP-1 companion products. Delivery format innovation — particularly oral dissolving films, sublingual strips, and functional stick packs — is driving premium pricing and DTC brand differentiation.

Against this backdrop, the demand for qualified U.S.-based contract manufacturers has never been higher. Tariff changes in 2026 have significantly increased the cost of offshore supplement production, while growing quality expectations from Amazon, retailers, and consumers are raising the bar for cGMP compliance documentation.

What Is a Dietary Supplement Contract Manufacturer?

A dietary supplement contract manufacturer (CMO or CDMO) is an FDA-registered company that produces supplement products to your formulation specifications. The brand owner supplies the formula and label; the CMO provides the cGMP-certified facility, equipment, testing, and regulatory documentation. CMOs differ from private label suppliers, who offer pre-made stock formulas, and from co-packers, who package bulk product you supply.

A dietary supplement contract manufacturer — also called a CMO (contract manufacturing organization) or CDMO (contract development and manufacturing organization) — is a company that produces supplement products to your specifications under your brand. The brand owner owns the formula, the label, and the customer relationship. The CMO owns the production facility, equipment, and quality systems.

This arrangement is distinct from two commonly confused alternatives:

Private label manufacturing — the CMO has pre-developed stock formulas; you select one, add your label, and sell it. Faster and cheaper, but no formula differentiation.
Co-packing / toll manufacturing — you supply the finished bulk product; the CMO packages it under your label. You control the formula but need your own manufacturing capability for the bulk.

A full-service CDMO handles the entire process: formulation R&D, ingredient sourcing, manufacturing, analytical testing, packaging, and regulatory documentation. Brands that partner with a CDMO own a proprietary formula with full batch records and COAs — the documentation infrastructure that supports Amazon selling, retail distribution, and international export.

Types of Supplement CMOs: Which Model Fits Your Brand?

Full-Service CDMOs

Full-service CDMOs offer formulation development, ingredient procurement, manufacturing, QC testing, and packaging under one roof. They are the best fit for brands building proprietary formulas with long-term IP value. Timeline is longer (4–8 months for custom formulas) and MOQs are higher, but the output is a differentiated, fully documented product. Atrium Scientific is a full-service CDMO specializing in specialty dosage forms: ODFs, sublingual strips, suppositories, oral care, and topicals.

Specialty Format CMOs

Specialty format CMOs focus on one or a few dosage forms that require unique equipment and expertise — gummies, ODFs, suppositories, softgels, or liquids. If your product requires a specialty format, working with a CMO that focuses on it produces better results than a generalist who offers it as a secondary capability. Specialty CMOs typically have more formulation depth and better equipment validation for their focus formats.

Private Label Stock Formula Suppliers

Private label CMOs maintain catalogs of pre-made formulas across popular supplement categories. Brands select, customize packaging, and launch quickly — often in 6–10 weeks. MOQs are low (sometimes 500–1,000 units). The tradeoff: no formula differentiation; any competitor can order the same product with a different label. Best for brands testing a market or launching a complementary SKU fast rather than building a core brand asset.

Toll Manufacturers and Co-Packers

Toll manufacturers process your bulk ingredients or semi-finished product using their equipment. Co-packers package your finished bulk into consumer units. These models work for brands that have their own formulas and bulk manufacturing relationships but lack packaging infrastructure. They are less relevant for most supplement brand startups.

The Regulatory Framework: 21 CFR Part 111 and FDA Registration

Dietary supplements in the United States are regulated under the Dietary Supplement Health and Education Act of 1994 (DSHEA) and manufactured under 21 CFR Part 111, the Current Good Manufacturing Practices regulation for dietary supplements. Understanding these frameworks is essential for evaluating CMOs — and for protecting your brand.

21 CFR Part 111 (Dietary Supplement cGMP)

21 CFR Part 111 requires dietary supplement manufacturers to establish and follow written procedures for identity testing of all incoming raw materials, batch production records, finished product testing, equipment cleaning and maintenance, employee training, and complaint handling. Every batch must have a production record, and identity and purity must be verified before release. Non-compliance carries significant consequences: FDA warning letters, consent decrees, and product recalls.

FDA Registration vs. FDA Approval

A critical distinction: the FDA does not approve dietary supplement products. FDA registration — required under the Bioterrorism Act of 2002 — is a mandatory administrative requirement for food and supplement facilities; it is not an endorsement or quality certification. Any CMO claiming their products are “FDA approved” is making an inaccurate claim. What you should require: FDA-registered facility (verifiable at FDA.gov) and a current cGMP certification from a recognized third-party auditor.

Third-Party cGMP Certification

Self-declared cGMP compliance is not sufficient. Third-party certification from organizations such as NSF International, Informed Choice, UL, the Natural Products Association (NPA), or BSCG means an independent auditor has reviewed the facility’s SOPs, equipment, testing protocols, and batch records against the Part 111 standard. Some retailers (Whole Foods, major natural channel distributors) and Amazon require third-party cGMP certification. Verify the certification is current — audits are typically annual or biannual.

Supplement Dosage Forms: What Your CMO Must Be Able to Produce

Not all CMOs manufacture all dosage forms. Dosage form capability should be your first filter when evaluating manufacturers — before price, before location, before anything else. Here is an overview of the major supplement dosage forms and what distinguishes their manufacturing requirements:

Dietary supplement dosage forms including capsules, tablets, powders, and oral dissolving films — The dosage form your product requires should be the first filter when evaluating contract manufacturers

Hard-shell capsules (HPMC or gelatin) — the most common supplement format; wide CMO availability; MOQ typically 10,000–50,000 units for custom formulas
Softgels — requires specialized encapsulation equipment; best for oil-soluble actives; fewer qualified CMOs than hard-shell capsule producers
Tablets — compressed powder; requires tablet presses and coating equipment; good for high-dose formulas; lower per-unit cost at scale
Gummies — fast-growing format; requires gelatin or pectin deposition equipment; active ingredient stability (especially heat-sensitive compounds like probiotics) is a challenge; MOQ typically 20,000–50,000 units
Powders and stick packs — flexible for high-dose formulas; stick pack manufacturing requires sacheting equipment; MOQ varies widely (1,000–10,000 units)
Oral dissolving films (ODFs) / sublingual strips — specialty equipment; only a handful of U.S. CMOs; MOQ can be as low as 3,000 units at specialty manufacturers; ideal for fast-onset actives
Suppositories — rectal and vaginal; requires melt-and-pour or compression equipment; very few USA-based manufacturers qualified for this format
Topicals — creams, serums, gels; regulated as cosmetics or OTC drugs depending on claims; requires emulsification and filling equipment
Liquids and tinctures — requires liquid filling lines; alcohol-based tinctures need specific licensing considerations

Brands developing products in specialty formats — ODFs, suppositories, or topicals — should work exclusively with CMOs that focus on those formats rather than offering them as secondary capabilities. The equipment complexity and formulation expertise required are substantially higher than for capsules or tablets.

How to Evaluate a Dietary Supplement Contract Manufacturer

Eight criteria that separate qualified CMO partners from risky ones:

1. cGMP Certification Status

Request the current third-party cGMP certificate. Verify the certifying body (NSF, NPA, UL, Informed Choice — not a self-certification), the certificate expiration date, and that the facility address matches where your product will be made. A 2-year-old certificate from a certifier you can’t verify independently is a red flag.

2. Dosage Form Specialization

Confirm the CMO’s primary dosage form expertise matches your product. Ask what percentage of their production volume is your dosage form, how many batches per month they run of it, and what their equipment capacity is. A CMO that primarily makes capsules and “also does gummies” will produce inferior gummies versus a gummy-specialist.

3. In-House Analytical Testing

In-house laboratory capability (HPLC, ICP-MS, microbial testing) means faster release times and more control over your QC timeline. CMOs that outsource all testing to third-party labs add weeks to production timelines and have less direct visibility into batch quality. Ask specifically about identity testing for raw materials and finished product potency testing methodology.

4. MOQ Alignment

Match your first-run MOQ to your 90-day sales forecast, not your aspirational 12-month projection. A CMO with a 50,000-unit MOQ is not the right partner for a brand launching to validate market fit. Conversely, a CMO with a 500-unit MOQ likely lacks the production infrastructure to scale with you when demand grows. Find a CMO whose volume sweet spot aligns with your planned first 2–3 runs.

5. Formulation Development Support

Some CMOs are manufacturers only — they require you to provide a complete formula before production begins. Others have in-house R&D teams that will develop your formula from a concept brief. If you don’t have a formulator, you need a CDMO with R&D support. If you have your own formulation team, a contract-only manufacturer may be suitable.

6. Raw Material Sourcing and Supplier Qualification

Ask how the CMO qualifies ingredient suppliers. A robust supplier qualification program includes vendor audits, COA review, and identity testing on receipt. CMOs that accept ingredients from unqualified suppliers introduce contamination, adulteration, and potency risks that will ultimately become your brand’s liability.

7. International Regulatory Support

If you plan to sell into Canada, the EU, Australia, or the UK, your CMO must be able to provide the documentation those markets require: PIC/S GMP certificates for Australian TGA clearance, Health Canada’s SNN and NHP file support, EU Food Supplements Directive compliance documentation. Not all U.S. CMOs have experience navigating international requirements — ask specifically which export markets they have supported.

8. Communication and Transparency

Manufacturing relationships span months to years. A CMO that goes silent during production, provides vague timelines, or resists sharing batch records will cost you more in delays and rework than a slightly higher price point ever would. Pay attention to response time and documentation transparency during the vetting process — they are leading indicators of how the manufacturing relationship will function.

Timelines: From Signed Contract to First Delivered Shipment

Brands consistently underestimate how long supplement manufacturing takes. Here are realistic timelines for the two main models:

Custom Formula Development and Manufacturing

Formulation development: 4–8 weeks (stability data may extend this for novel actives)
Formula review and approval: 1–2 weeks
Ingredient sourcing and qualification: 2–4 weeks (longer if specialty or international-sourced ingredients)
Manufacturing and in-process QC: 1–3 weeks
Finished product QC testing and release: 2–4 weeks
Packaging and fulfillment: 1–2 weeks
Total: 4–6 months, plan for 7–8 for first runs

Stock Formula / Private Label

Formula selection and agreement: 1–2 weeks
Label design and compliance review: 2–3 weeks
Manufacturing and QC: 2–4 weeks
Total: 6–10 weeks for established stock formulas

Build buffer into every timeline. First production runs almost always take longer than subsequent runs. Regulatory, labeling, or ingredient issues can add 2–6 weeks to either model. Brands launching for a seasonal peak (Q4 holiday, New Year, summer) should back-calculate from their launch date and start the CMO conversation 9–12 months out for custom formulas.

Why 2025 Tariff Changes Are Accelerating Domestic Manufacturing

USA domestic dietary supplement manufacturing — 2025 tariff changes accelerating reshoring from overseas — 2025 tariff changes have shifted the cost calculation significantly toward U.S.-based supplement manufacturing

The 2025 tariff changes — including duties exceeding 100% on certain Chinese-manufactured pharmaceutical and supplement goods — have fundamentally changed the economics of offshore supplement production. Brands that previously sourced finished goods or packaging from China are seeing landed costs increase dramatically, while supply chain visibility has decreased as suppliers navigate uncertainty.

The elimination of the De Minimis exemption (which previously allowed imports under $800 to enter duty-free) has created particular disruption for direct-to-consumer supplement brands importing small production runs or sample quantities from overseas manufacturers.

Beyond cost, domestic manufacturing provides structural advantages that are difficult to quantify but strategically significant: faster response to demand fluctuations, direct facility auditing capability, cleaner supply chain documentation for Amazon and retail partners, and the ability to make “Made in USA” claims that increasingly influence consumer purchase decisions in the supplement category.

For specialty formats — ODFs, suppositories, and oral care — domestic manufacturing was already the dominant model because qualified overseas CMOs for these formats are scarce. For capsule and tablet brands that have historically used Chinese CMOs, the combination of tariff costs and quality documentation requirements is making U.S. sourcing more competitive than at any point in the past decade.

Why Atrium Scientific for Dietary Supplement Contract Manufacturing

Atrium Scientific OEM contract manufacturing process overview — dietary supplement and oral care production — Atrium Scientific’s end-to-end OEM process covers formulation, manufacturing, QC, and documentation for specialty supplement formats

Atrium Scientific is a USA-based, FDA-registered, cGMP-certified contract development and manufacturing organization (CDMO) specializing in advanced supplement delivery formats. Our core capabilities — oral dissolving films, sublingual strips, suppositories, oral care products, stick pack powders, and topicals — serve brands that require formulation expertise beyond what generalist capsule manufacturers can deliver.

Our in-house R&D team develops custom formulas from concept briefs, including taste masking for bitter actives, encapsulation systems, and specialized base selection for suppositories and topicals. Every formula is validated with stability testing and sensory panel evaluation before production approval. We do not release batches that fail our quality standards.

Atrium’s low minimum order quantities — from 3,000 units for ODFs — make it practical for emerging brands to validate products in real market conditions before committing to large production runs. Our documentation package (COAs, batch records, cGMP certificate, FDA registration confirmation) satisfies the requirements of Amazon, major retailers, and international regulatory authorities including Australia’s TGA and Canada’s Health Canada.

All production takes place in our domestic facility. No overseas subcontracting, no supply chain opacity, no tariff exposure.

For more context, see our guide on contract manufacturing products.

For more context, see our guide on 10 questions to ask a contract manufacturer.

For more context, see our guide on minimum order quantities by dosage form.

For more context, see our guide on cGMP certification requirements.

Ready to evaluate Atrium Scientific as your contract manufacturing partner? Contact our team to discuss your dosage form, formulation requirements, and production timeline.

Frequently Asked Questions About Dietary Supplement Contract Manufacturing

What is a dietary supplement contract manufacturer?

A dietary supplement contract manufacturer (CMO or CDMO) produces supplement products to your formulation specifications under your brand. They handle manufacturing, QC testing, packaging, and documentation under cGMP regulations while you own the brand, formula, and customer relationship.

What is the minimum order quantity for supplement contract manufacturing?

MOQs vary significantly by dosage form. Capsules typically start at 10,000–50,000 units for custom formulas. ODFs can start as low as 3,000 units at specialty manufacturers. Gummies typically require 20,000–50,000 units. Powders and stick packs often start at 1,000–5,000 units. Always confirm MOQ by dosage form with specific CMOs.

How long does supplement contract manufacturing take?

Custom supplement manufacturing typically takes 4–8 months from signed agreement to first delivery. Stock/private label products can move in 6–10 weeks. Build buffer into every timeline — first production runs almost always take longer than subsequent runs, and regulatory or ingredient issues can add 2–6 weeks.

Do I need FDA approval to sell dietary supplements?

No. The FDA does not approve dietary supplement products. Your manufacturer must be FDA registered and operate under 21 CFR Part 111 cGMP regulations. You are responsible for ensuring your product is safe and that any claims are truthful and substantiated. The FDA takes enforcement action after the fact if products are unsafe or mislabeled.

How do I vet a U.S. dietary supplement contract manufacturer?

Filter first on dosage form capability, then verify FDA registration, current third-party cGMP certification, in-house analytical testing, MOQ alignment, and formulation support availability. Request references and documentation samples before committing to a production run. Response time and documentation transparency during vetting are leading indicators of the manufacturing relationship’s quality.

What is 21 CFR Part 111?

21 CFR Part 111 is the FDA’s Current Good Manufacturing Practices regulation for dietary supplements. It requires manufacturers to verify the identity of all incoming ingredients, maintain batch production records, test finished products, and document all quality control procedures. Brands that work with 21 CFR Part 111-compliant CMOs have documented evidence of quality control that protects against recalls, retailer audits, and FDA enforcement.